Biogen shares drop as big clinics say they won’t administer controversial Alzheimer’s drug

CNBC Television published this video item, entitled “Biogen shares drop as big clinics say they won’t administer controversial Alzheimer’s drug” – below is their description. Cleveland Clinic and Mt. Sinai won’t administer Aduhelm, a controversial but recently FDA-approved Alzheimer’s drug. Both clinics issued statements which said they have problems with the FDA approval process for … Read more Biogen shares drop as big clinics say they won’t administer controversial Alzheimer’s drug

Third FDA advisor resigns after Biogen’s Alzheimer’s drug approval

CNBC Television published this video item, entitled “Third FDA advisor resigns after Biogen’s Alzheimer’s drug approval” – below is their description. A third FDA advisor has resigned following last week’s controversial accelerated approval of Biogen’s Alzheimer’s drug. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi A third member of … Read more Third FDA advisor resigns after Biogen’s Alzheimer’s drug approval

New drug treatment slows progression of Alzheimer’s | 9 News Australia

9 News Australia published this video item, entitled “New drug treatment slows progression of Alzheimer’s | 9 News Australia” – below is their description. Scientists are debating the effectiveness of a new drug treatment for Alzheimer’s disease. 9 News Australia YouTube Channel Got a comment? Leave your thoughts in the comments section, below. Please note … Read more New drug treatment slows progression of Alzheimer’s | 9 News Australia

US FDA approves 1st new Alzheimer’s drug in nearly 20 years

Global News published this video item, entitled “US FDA approves 1st new Alzheimer’s drug in nearly 20 years” – below is their description. American government health officials have approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow … Read more US FDA approves 1st new Alzheimer’s drug in nearly 20 years

Cramer: There will be push back on Biogen’s Alzheimer’s drug price

CNBC Television published this video item, entitled “Cramer: There will be push back on Biogen’s Alzheimer’s drug price” – below is their description. The Food and Drug Administration on Monday approved Biogen’s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer’s and … Read more Cramer: There will be push back on Biogen’s Alzheimer’s drug price

Equity analyst on why he remains a ‘skeptic’ on Biogen’s new Alzheimer’s drug

CNBC Television published this video item, entitled “Equity analyst on why he remains a ‘skeptic’ on Biogen’s new Alzheimer’s drug” – below is their description. The Food and Drug Administration on Monday approved Biogen’s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people living with … Read more Equity analyst on why he remains a ‘skeptic’ on Biogen’s new Alzheimer’s drug

US approves controversial new Alzheimer’s drug

Al Jazeera English published this video item, entitled “US approves controversial new Alzheimer’s drug” – below is their description. US government health regulators have approved the first medication called aducanumab to treat Alzheimer’s disease in nearly two decades. Its makers say it reduces fatty plaque in the brain which is the main reason for mental … Read more US approves controversial new Alzheimer’s drug

FDA approves new treatment for Alzheimer’s disease

ABC News published this video item, entitled “FDA approves new treatment for Alzheimer’s disease” – below is their description. BioGen’s “Aduhelm” is a monthly injection intended to slow cognitive decline in patients with early stages of the disease. The FDA granted the drug approval as a new clinical trial begins. #WorldNewsTonight #Alzheimers #NewTreatment ABC News … Read more FDA approves new treatment for Alzheimer’s disease

Biogen reopens following FDA approval of company’s Alzheimer drug

CNBC Television published this video item, entitled “Biogen reopens following FDA approval of company’s Alzheimer drug” – below is their description. CNBC’s Meg Tirrell discusses the surge in shares of Biogen after the FDA gave the ok to the company’s Alzheimer’s drug. For access to live and exclusive video from CNBC subscribe to CNBC PRO: … Read more Biogen reopens following FDA approval of company’s Alzheimer drug

FDA’s historic approval of Biogen’s Alzheimer’s drug

CNBC Television published this video item, entitled “FDA’s historic approval of Biogen’s Alzheimer’s drug” – below is their description. CNBC’s Meg Tirrell on the FDA approval of Biogen’s new Alzheimer’s drug. With CNBC’s Brian Sullivan and the Fast Money traders, Guy Adami, Tim Seymour and Karen Mills. For access to live and exclusive video from … Read more FDA’s historic approval of Biogen’s Alzheimer’s drug

LIVE: FDA Approves First New Alzheimer’s Drug in Nearly 20 Years | Top News

Bloomberg Quicktake: Now published this video item, entitled “LIVE: FDA Approves First New Alzheimer’s Drug in Nearly 20 Years | Top News” – below is their description. (June 7) Biogen received approval for its controversial Alzheimer’s disease therapy, a landmark decision that stands to dramatically change treatment for the debilitating brain condition. After decades of … Read more LIVE: FDA Approves First New Alzheimer’s Drug in Nearly 20 Years | Top News

FDA Approves First New Alzheimer’s Drug in Nearly 20 Years

Bloomberg Quicktake: Now published this video item, entitled “FDA Approves First New Alzheimer’s Drug in Nearly 20 Years” – below is their description. U.S. approval of a medication that removes a key marker for Alzheimer’s disease sharply divided clinicians and advocates over whether it has the ability to change the disease’s progress and how it … Read more FDA Approves First New Alzheimer’s Drug in Nearly 20 Years

Biogen CEO Sees New Chapter in Fight Against Alzheimer’s

Bloomberg Markets and Finance published this video item, entitled “Biogen CEO Sees New Chapter in Fight Against Alzheimer’s” – below is their description. Jun.07 — Biogen CEO Michel Vounatsos discusses the implications of the FDA’s approval of the company’s controversial Alzheimer’s disease therapy, which will be sold under the name Aduhelm. He speaks on “Bloomberg … Read more Biogen CEO Sees New Chapter in Fight Against Alzheimer’s

FDA Gives Green Light to Biogen’s Alzheimer’s Drug

Bloomberg Markets and Finance published this video item, entitled “FDA Gives Green Light to Biogen’s Alzheimer’s Drug” – below is their description. Jun.07 — The FDA approved Biogen’s controversial Alzheimer’s disease therapy, which will be sold under the name Aduhelm. The drug works by removing amyloid, a harmful protein that clogs the brains of Alzheimer’s patients. … Read more FDA Gives Green Light to Biogen’s Alzheimer’s Drug

85-year-old with Alzheimer’s a victim of unethical sale at The Source, says son

CBC News published this video item, entitled “85-year-old with Alzheimer’s a victim of unethical sale at The Source, says son” – below is their description. Ross Miller, an 85-year-old with Alzheimer’s disease, went to The Source in Toronto to buy a TV. Instead, a salesperson sold him much more than he intended to buy, he … Read more 85-year-old with Alzheimer’s a victim of unethical sale at The Source, says son